(Q92380610)
Statements
Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Behçet's disease without formation of antidrug antibodies (English)
Diana M Verboom
Tim B van der Houwen
Jasper H Kappen
Paul L A van Daele
Willem A Dik
Marco W J Schreurs
P Martin van Hagen
Jan A M van Laar